Showing results (101-110 of 854) with videos related to
Sort By:
Pageof 86
Current Hematologic Malignancy Reports|April 29, 2010
Frontline therapy in mantle cell lymphoma: the role of high-dose therapy and integration of new agentsBrad S KahlCurrent Hematologic Malignancy Reports|April 29, 2010
Beyond R-CHOP and the IPI in large-cell lymphoma: molecular markers as an opportunity for stratificationJason R Westin, Luis E FayadCurrent Hematologic Malignancy Reports|April 29, 2010
Update on the World Health Organization classification of peripheral T-cell lymphomasHilary M O'Leary, Kerry J SavageCurrent Hematologic Malignancy Reports|April 29, 2010
Hemopoietic stem cell transplantation in T-cell malignancies: who, when, and how?Francesco d'Amore, Esa Jantunen, Thomas RelanderCurrent Hematologic Malignancy Reports|April 29, 2010
Predicting the response of CML patients to tyrosine kinase inhibitor therapyDeborah L White, Timothy P HughesCurrent Hematologic Malignancy Reports|April 29, 2010
Chronic myelogenous leukemia stem cells: What's new?Mhairi CoplandCurrent Hematologic Malignancy Reports|April 29, 2010
The role of bisphosphonates in multiple myelomaJessica Levy, G David RoodmanCurrent Hematologic Malignancy Reports|April 29, 2010
Do we know more about essential thrombocythemia because of JAK2V617F?Claire HarrisonCurrent Hematologic Malignancy Reports|April 29, 2010
Use of alemtuzumab and rituximab consolidation in CLL: Pros and consThomas Elter, Barbara F Eichhorst, Clemens-Martin WendtnerCurrent Hematologic Malignancy Reports|April 29, 2010
Alemtuzumab to treat refractory autoimmune hemolytic anemia or thrombocytopenia in chronic lymphocytic leukemiaAnders Osterborg, Claes Karlsson, Jeanette LundinPageof 86